BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 11073979)

  • 1. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.
    Lee KS; Kim HJ; Li QL; Chi XZ; Ueta C; Komori T; Wozney JM; Kim EG; Choi JY; Ryoo HM; Bae SC
    Mol Cell Biol; 2000 Dec; 20(23):8783-92. PubMed ID: 11073979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5.
    Nishimura R; Hata K; Harris SE; Ikeda F; Yoneda T
    Bone; 2002 Aug; 31(2):303-12. PubMed ID: 12151083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intimate relationship between TGF-beta/BMP signaling and runt domain transcription factor, PEBP2/CBF.
    Bae SC; Lee KS; Zhang YW; Ito Y
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S48-55. PubMed ID: 11263665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein.
    Lee KS; Hong SH; Bae SC
    Oncogene; 2002 Oct; 21(47):7156-63. PubMed ID: 12370805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts.
    Yamamoto N; Akiyama S; Katagiri T; Namiki M; Kurokawa T; Suda T
    Biochem Biophys Res Commun; 1997 Sep; 238(2):574-80. PubMed ID: 9299554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bone morphogenetic protein-2 and transforming growth factor beta1 on gene expression of transcription factors, AJ18 and Runx2 in cultured osteoblastic cells.
    Takagi M; Kamiya N; Takahashi T; Ito S; Hasegawa M; Suzuki N; Nakanishi K
    J Mol Histol; 2004 Jan; 35(1):81-90. PubMed ID: 15323353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
    Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
    J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
    Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
    J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.
    Gu K; Zhang L; Jin T; Rutherford RB
    Cells Tissues Organs; 2004; 176(1-3):28-40. PubMed ID: 14745233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12.
    Nishimura R; Kato Y; Chen D; Harris SE; Mundy GR; Yoneda T
    J Biol Chem; 1998 Jan; 273(4):1872-9. PubMed ID: 9442019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of the Ski-interacting protein (SKIP) on differentiation induced by transforming growth factor-beta1 and bone morphogenetic protein-2 in C2C12 cells.
    Figueroa JD; Hayman MJ
    Exp Cell Res; 2004 Jun; 296(2):163-72. PubMed ID: 15149847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression.
    Lee MH; Kim YJ; Kim HJ; Park HD; Kang AR; Kyung HM; Sung JH; Wozney JM; Kim HJ; Ryoo HM
    J Biol Chem; 2003 Sep; 278(36):34387-94. PubMed ID: 12815054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation.
    Spinella-Jaegle S; Roman-Roman S; Faucheu C; Dunn FW; Kawai S; Galléa S; Stiot V; Blanchet AM; Courtois B; Baron R; Rawadi G
    Bone; 2001 Oct; 29(4):323-30. PubMed ID: 11595614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage.
    Sowa H; Kaji H; Canaff L; Hendy GN; Tsukamoto T; Yamaguchi T; Miyazono K; Sugimoto T; Chihara K
    J Biol Chem; 2003 Jun; 278(23):21058-69. PubMed ID: 12649288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smurf1 facilitates myogenic differentiation and antagonizes the bone morphogenetic protein-2-induced osteoblast conversion by targeting Smad5 for degradation.
    Ying SX; Hussain ZJ; Zhang YE
    J Biol Chem; 2003 Oct; 278(40):39029-36. PubMed ID: 12871975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription.
    Afzal F; Pratap J; Ito K; Ito Y; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Javed A
    J Cell Physiol; 2005 Jul; 204(1):63-72. PubMed ID: 15573378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7.
    Tou L; Quibria N; Alexander JM
    Mol Cell Endocrinol; 2003 Jul; 205(1-2):121-9. PubMed ID: 12890574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).
    Pardali K; Kowanetz M; Heldin CH; Moustakas A
    J Cell Physiol; 2005 Jul; 204(1):260-72. PubMed ID: 15690394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
    Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
    Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway.
    Haÿ E; Lemonnier J; Fromigué O; Marie PJ
    J Biol Chem; 2001 Aug; 276(31):29028-36. PubMed ID: 11395480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.